Principal Financial Group Inc. lessened its stake in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 11.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 157,776 shares of the financial services provider's stock after selling 21,393 shares during the quarter. Principal Financial Group Inc. owned about 0.38% of Trupanion worth $6,623,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC boosted its holdings in Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider's stock valued at $61,000 after purchasing an additional 596 shares during the period. Headlands Technologies LLC acquired a new position in Trupanion during the second quarter worth about $162,000. Oppenheimer Asset Management Inc. acquired a new stake in Trupanion during the 2nd quarter valued at approximately $235,000. Handelsbanken Fonder AB acquired a new stake in Trupanion in the 3rd quarter valued at $248,000. Finally, Bayesian Capital Management LP bought a new stake in shares of Trupanion during the 1st quarter worth $253,000.
Insiders Place Their Bets
In other Trupanion news, Director Murray B. Low sold 2,000 shares of Trupanion stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total value of $105,340.00. Following the transaction, the director now directly owns 131,513 shares of the company's stock, valued at $6,926,789.71. The trade was a 1.50 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Margaret Tooth sold 7,500 shares of the business's stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares of the company's stock, valued at $4,647,256.32. This represents a 6.98 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 10,124 shares of company stock valued at $482,981 over the last three months. 5.50% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
TRUP has been the subject of a number of recent analyst reports. Northland Securities upped their target price on Trupanion from $45.00 to $50.00 and gave the company a "market perform" rating in a report on Thursday, October 31st. Bank of America upped their price target on Trupanion from $47.00 to $56.00 and gave the stock a "buy" rating in a report on Friday, September 20th. Evercore ISI upgraded Trupanion to a "strong-buy" rating in a research note on Friday, August 9th. Piper Sandler increased their price objective on shares of Trupanion from $45.00 to $57.00 and gave the stock a "neutral" rating in a report on Thursday, October 31st. Finally, Stifel Nicolaus boosted their price target on shares of Trupanion from $30.00 to $40.00 and gave the stock a "hold" rating in a research report on Monday, September 23rd. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Trupanion currently has an average rating of "Moderate Buy" and an average target price of $44.67.
Read Our Latest Research Report on Trupanion
Trupanion Trading Down 2.2 %
TRUP stock traded down $1.14 during midday trading on Wednesday, reaching $51.82. The company's stock had a trading volume of 394,542 shares, compared to its average volume of 681,329. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of -165.50 and a beta of 1.69. The stock has a fifty day simple moving average of $48.58 and a two-hundred day simple moving average of $38.86. Trupanion, Inc. has a 1 year low of $19.69 and a 1 year high of $57.90.
Trupanion (NASDAQ:TRUP - Get Free Report) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The firm had revenue of $327.50 million during the quarter, compared to analysts' expectations of $321.79 million. During the same period in the prior year, the firm earned ($0.10) EPS. The business's revenue was up 14.6% on a year-over-year basis. On average, equities research analysts predict that Trupanion, Inc. will post -0.23 EPS for the current year.
Trupanion Company Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.